Patents by Inventor Hei Jason Chan

Hei Jason Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers of breast cancer and methods for the use thereof
    Patent number: 11268152
    Abstract: In accordance with the present invention, the single gene SERPINA1 has been identified as a significant predictor of survival in ER+ and ER+/HER2+ breast cancer patients. For example, patients with ER+/FIER2+ breast cancer generally have a worse outcome compared to ER+/FIER2? and ER?/FIER2+ patients. Currently there is no known predictive marker for the treatment C outcome of ER+ and ER+/FIER2+ breast cancers, thus the ability of SERPINA1 to predict the survival of this intrinsic subtype of breast cancer patients is valuable.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: March 8, 2022
    Assignee: CITY OF HOPE
    Inventors: Shiuan Chen, Hei Jason Chan
  • MARKERS OF BREAST CANCER AND METHODS FOR THE USE THEREOF
    Publication number: 20180264109
    Abstract: In accordance with the present invention, the single gene SERPINA1 has been identified as a significant predictor of survival in ER+ and ER+/HER2+ breast cancer patients. For example, patients with ER+/FIER2+ breast cancer generally have a worse outcome compared to ER+/FIER2? and ER?/FIER2+ patients. Currently there is no known predictive marker for the treatment C outcome of ER+ and ER+/FIER2+ breast cancers, thus the ability of SERPINA1 to predict the survival of this intrinsic subtype of breast cancer patients is valuable.
    Type: Application
    Filed: January 19, 2016
    Publication date: September 20, 2018
    Inventors: Shiuan Chen, Hei Jason Chan